NEW YORK (GenomeWeb) – Canon BioMedical said today that it has signed a distribution agreement for its Novallele line of genotyping and copy number assays in Austria, Germany, and Switzerland.
Under the terms of the deal, Germany's Biozol Diagnostica Vertrieb will distribute Novallele genotyping assays, controls, and reagents, as well as Novallele copy number assays and master mix, in the three countries. Additional terms were not disclosed.
The assays are designed to detect SNPs, small and large indels, and copy number variations using PCR followed by high-resolution melting analysis, and can be performed on any thermal cycler capable of high-resolution melting, the company said.
In September, Canon BioMedical inked a distribution deal for its Novallele genotyping products in Belgium, the Netherlands, and Luxembourg with Sanbio. The company introduced Novallele copy number assays for spinal muscular atrophy research last month.